Get the Stockscreener App
15.24
2.74%
-0.43
After Hours:
15.24
Syndax Pharmaceuticals Inc Stock (SNDX) Latest News
Syndax Announces Participation in March Investor Conferences - The Manila Times
Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Up 6.7%Still a Buy? - MarketBeat
Syndax to Announce Fourth Quarter and Full Year 2024 - GlobeNewswire
Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025 - The Manila Times
Syndax Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - Nasdaq
When Will Syndax Report Q4 Earnings? Key Date and Access Details Inside - StockTitan
Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer - AOL
Syndax Pharmaceuticals (SNDX) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Should investors be concerned about SNDX’s high price-to-sales ratio? - US Post News
Syndax Pharmaceuticals (SNDX) Projected to Post Earnings on Tuesday - MarketBeat
Here's Why We're Watching Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation - Yahoo Finance
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
When (SNDX) Moves Investors should Listen - Stock Traders Daily
Syndax Pharmaceuticals' SWOT analysis: stock poised for growth with FDA approvals - Investing.com
Insider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Insider Sells 4,618 Shares of Stock - MarketBeat
Insider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CFO Sells 3,777 Shares of Stock - MarketBeat
Michael A. Metzger Sells 13,288 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock - MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Syndax pharmaceuticals CFO Keith Goldan sells $58,558 in stock - MSN
Don't Ignore The Insider Selling In Syndax Pharmaceuticals - Simply Wall St
abrdn plc Takes Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Syndax pharmaceuticals CFO sells $58,558 in stock - MSN
Syndax Pharmaceuticals CEO sells $206,017 in shares - MSN
Syndax pharmaceuticals CFO Keith Goldan sells $58,558 in stock By Investing.com - Investing.com Australia
Syndax pharmaceuticals CFO sells $58,558 in stock By Investing.com - Investing.com Nigeria
Syndax Pharmaceuticals CEO sells $206,017 in shares By Investing.com - Investing.com South Africa
Syndax Pharmaceuticals Executives Sell Shares for Tax Obligations - TradingView
Is Syndax Pharmaceuticals Inc (SNDX) positioned for future growth? - SETE News
2 ‘Strong Buy’ Growth Stocks Poised For 141% To 193% Gains, According To Wall Street - Barchart
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap UpShould You Buy? - MarketBeat
Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm - GlobeNewswire Inc.
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):